The collection and reporting of TCM decoction pieces will be carried out in many places, and the industry will be reshaped soon!

Decoction pieces of traditional Chinese medicine are traditional Chinese medicines that can be directly used in clinical Chinese medicine after processing according to the theory of traditional Chinese medicine and the processing method of traditional Chinese medicine
.
In recent years, the Chinese medicine decoction pieces industry has developed rapidly.
The industry expects that with the promotion of favorable national policies, the Chinese medicine decoction pieces industry is expected to usher in heavy volume in 2022, driving the growth of related companies' performance
.
It is worth mentioning that the current centralized procurement has been normalized.
After the chemical drugs, insulin, high-value consumables, etc.
have entered the centralized drug procurement, there is also news that Chinese herbal pieces will enter the centralized procurement
.
Recently, relevant notices have been issued in many places to clearly carry out the work of reporting the quantity of Chinese herbal medicines
.
For example, on March 10, the Shanxi Provincial Pharmaceutical Equipment Centralized Bidding and Purchasing Center stated that in accordance with the requirements of the Sanming Procurement Alliance (Nationwide) Office's "Notice on Carrying out Data Reporting Work for Some Varieties of Chinese Herbal Pieces", it organized medical institutions in Shanxi Province to carry out centralized delivery of Chinese Herbal Pieces.
Fill in and report the purchase data of related varieties of quantity purchases
.
Judging from the list of TCM decoction pieces combined with quantity procurement, there are 21 TCM decoction pieces, including Astragalus, Codonopsis, Honeysuckle, Angelica, Safflower, Tianma, Ophiopogon japonicus, Coptis, Taizishen, Baishao, Licorice, Dilong, Salvia miltiorrhiza, Scutellaria baicalensis, Chinese yam, dandelion, peony bark, and Platycodon grandiflorum are all common varieties of Chinese herbal medicines
.
In addition to clarifying the varieties of centralized procurement, Shanxi Province also sets specifications for selection and distribution of each variety in the list, which will help to force the standardization and standardization of the market for Chinese herbal medicines
.
Previously, the Shandong Internet Chinese Herbal Medicine Trading Center also issued the "Notice on Carrying out the Data Reporting Work of Some TCM Decoction Pieces", which clearly stated that the data reporting work related to some TCM decoction pieces will be carried out
.
According to a report volume circulating in the industry at that time, there may be more than 190 kinds of Chinese herbal medicines involved in the centralized collection, among which there are many common Chinese herbal medicines such as Salvia, Bupleurum, Licorice and Angelica
.
The production areas of centralized procurement cover six major production areas of the top ten authentic Chinese medicinal materials in China, including Guanyao, Beiyao, Jiangnan medicine, Yungui medicine, Tibetan medicine and Western medicine.
45%
.
In addition, Ningxia has also issued a notification on the volume of Chinese herbal decoction pieces.
According to the time of the centralized collection and reporting of the three places, the deadline is at 24:00 on March 16.

.
The industry believes that with the advancement of the centralized procurement of Chinese herbal medicines, the whole industry is about to be reshaped
.
It is reported that in order to ensure the quality of the decoction pieces, Shandong Province will formulate relevant decoction pieces standards, and select the high-quality and affordable Chinese medicine decoction pieces that have established a planting base and traced the whole process
.
The whole process of traceability refers to the automatic collection, recording and monitoring of the whole process data from planting and harvesting to processing, from finished product testing to finished product warehousing
.
This also means that only varieties with guaranteed quality of decoction pieces can enter the centralized collection
.
With the development of the centralized procurement of traditional Chinese medicine pieces, it is expected that the entire market will be reshuffled, the small and medium-sized enterprises that do not meet the conditions will be eliminated, and the strong enterprises will become bigger and bigger
.
Under the pressure of centralized procurement, the decoction pieces enterprises in the whole industry may gradually do retrospective, which is expected to further improve the quality
.
At present, listed companies related to Chinese herbal decoction pieces have also attracted the attention of the industry, such as China Traditional Chinese Medicine, China Resources Sanjiu and Xiangxue Pharmaceutical, etc.
, all of which involve the production of Chinese herbal decoction pieces
.
At the end of February this year, China Resources Sanjiu has been surveyed by institutions for many times.
Regarding the impact of centralized procurement on the company's future performance, which is concerned by institutions, China Resources Sanjiu said that the scope of centralized procurement of Chinese patent medicines may be further expanded in the next few years, which is expected to affect the sales of products.
The price has a certain impact, but considering that the company's prescription drug business accounts for a large proportion of mainly exclusive varieties, and the sales cost of centralized procurement products will further decline, which may lead to the stability or growth of sales, so the profitability of traditional Chinese medicine varieties is guaranteed to a certain extent
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.